Concord Biotech
Shares of Concord Biotech fell for the seventh straight session on Friday, closing with declines of 9%. The stock settled at Rs 1,800.40 on the NSE, falling by Rs 172.90 over the previous closing price. It has fallen 15% in the last 7 trading sessions amid profit booking by investors following a 41% rally between May 21 and June 11. (Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)